Q2 2014 Holdings
Filed 2014-08-05 | 64 holdings | $92.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec, Inc.(BIIB) | Common | 09062X103 | $54.9M | 173,983 | 59.4% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $26.2M | 421,384 | 28.4% |
| Accuray, Inc.(ARAY) | Common | 004397105 | $6.4M | 731,943 | 7.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $3.9M | 61,595 | 4.2% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $124.8K | 1,504,712 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $81.1K | 944,092 | 0.1% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $54.6K | 193,466 | 0.1% |
| Amgen, Inc.(AMGN) | Common | 031162100 | $53.2K | 449,543 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $52.5K | 335,899 | 0.1% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $51.2K | 540,944 | 0.1% |
| Actavis plc | Shares | G0083B108 | $45.9K | 205,707 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $43.4K | 768,238 | 0.0% |
| Mylan, Inc. | Common | 628530107 | $33.6K | 652,209 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $29.0K | 123,322 | 0.0% |
| Allergan, Inc. | Common | 018490102 | $26.5K | 156,627 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $23.3K | 699,382 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $20.1K | 247,541 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $18.5K | 103,841 | 0.0% |
| Cubist Pharmaceuticals, Inc. | Common | 229678107 | $18.4K | 263,772 | 0.0% |
| ishares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $16.8K | 65,184 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $16.3K | 311,476 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | Shares | G50871105 | $14.1K | 95,957 | 0.0% |
| Celladon Corporation | Common | 15117E107 | $13.2K | 970,495 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $12.9K | 255,970 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $12.6K | 67,862 | 0.0% |
| Ironwood Pharmaceuticals, Inc.(IRWD) | Common | 46333X108 | $11.8K | 768,050 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $11.7K | 790,490 | 0.0% |
| Forest Laboratories, Inc. | Common | 345838106 | $10.9K | 109,875 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | Common | 427746102 | $10.8K | 873,940 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $10.7K | 286,540 | 0.0% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $10.5K | 404,731 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $10.3K | 344,683 | 0.0% |
| Catamaran Corporation | Common | 148887102 | $10.2K | 231,000 | 0.0% |
| Pfizer, Inc.(PFE) | Common | 717081103 | $9.9K | 334,957 | 0.0% |
| Bristol-Myers Squibb Co.(BMY) | Common | 110122108 | $9.8K | 202,600 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $9.5K | 212,541 | 0.0% |
| Perrigo Company plc(PRGO) | Shares | G97822103 | $9.2K | 62,952 | 0.0% |
| Endo International PLC | Shares | G30401106 | $8.8K | 126,215 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | Common | 45665G303 | $8.7K | 680,746 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $8.3K | 918,827 | 0.0% |
| PerkinElmer, Inc.(RVTY) | Common | 714046109 | $7.8K | 165,495 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $7.6K | 225,762 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $7.5K | 56,265 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $7.0K | 59,660 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $6.8K | 83,186 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | Common | 09060J106 | $6.1K | 501,553 | 0.0% |
| IntelliPharmaCeutics International Inc. | Common | 458173101 | $5.3K | 1,404,000 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $4.5K | 60,000 | 0.0% |
| Momenta Pharmaceuticals, Inc.(MNTA) | Common | 60877T100 | $4.3K | 353,475 | 0.0% |
| Merrimack Pharmaceuticals, Inc. | Common | 590328100 | $4.1K | 567,787 | 0.0% |